论文部分内容阅读
在天津市各级领导和市科委直接领导和关怀下,天津市生物化学制药厂勇于开拓,研制了广谱抗病毒新药聚肌胞注射液。他们积极引进先进设备,开发固相酶合成新工艺,采用新技术,使产品质量稳定,受到医疗单位和患者的欢迎。 1985年11月中国药学会主持召开了有新药审批专家等参加的全国聚肌胞专题会议。该会一致认为:聚肌胞的各项临床、药理、病理、毒理工作,采用严格的双盲法观察,数据可靠。基础研究比较系统完整,各项成果说明聚肌胞是安全有效的药物,具有
Directly under the leadership and care of Tianjin Municipal Science and Technology Commission leaders and municipal leaders at all levels, Tianjin Biochemical Pharmaceutical Factory has the courage to explore and develop a broad spectrum antiviral polychaete injection. They actively introduce advanced equipment, development of new technology of solid-phase enzyme synthesis, the use of new technologies, product quality and stability, by medical units and patients welcome. In 1985 November the Chinese Pharmaceutical Association presided over a national conference on polygons with new drug approval experts attended. The meeting agreed that: polygamy all clinical, pharmacological, pathological, toxicological work, the use of strict double-blind observation, the data is reliable. Basic research is more systematic and complete, the results show that poly-muscle cells are safe and effective drugs, with